Form 4: Becton Dickinson Executive Antoine C. Ezell Reports Stock Transactions

Executive Vice President Antoine C. Ezell of Becton Dickinson & Co. reports acquiring and disposing of company stock and stock appreciation rights.

Summary

• Antoine C. Ezell, an Executive Vice President at Becton Dickinson & Co., reported several transactions involving the company's stock on November 26, 2024.
• Ezell acquired 1,388 shares of common stock as restricted stock units and 2,619 shares upon vesting of performance-based equity awards.
• He also disposed of 1,357 shares to cover withholding taxes related to the vesting of these equity awards.
• Additionally, Ezell acquired 5,437 stock appreciation rights, which vest in four annual installments starting November 26, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transactions are routine and expected, reflecting standard executive compensation practices. The vesting of performance-based awards suggests positive performance.

Positives

• The acquisition of restricted stock units and performance-based equity awards indicates a continued alignment of executive interests with company performance.
• The vesting of performance-based equity awards suggests that performance targets were met.

Negatives

• The disposal of 1,357 shares to cover withholding taxes, while standard, reduces the executive's direct shareholding.

Risks

• The vesting schedule of the stock appreciation rights could create a future selling pressure if the executive chooses to exercise them.

Future Outlook

The stock appreciation rights will vest in four annual installments beginning November 26, 2025, which could lead to future stock transactions by the executive.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the stock ownership of key executives.

Comparison to Industry Standards

• The use of restricted stock units and performance-based equity awards is a standard practice for executive compensation in the healthcare industry, similar to companies like Medtronic and Abbott.
• The vesting schedule of the stock appreciation rights is also typical, often spanning several years to align executive interests with long-term company performance.

Stakeholder Impact

• The transactions have a minor impact on shareholders, as they are part of the executive compensation plan.
• The vesting of performance-based awards may be viewed positively by shareholders as it indicates the achievement of performance targets.

Key Dates

Keywords

Becton Dickinson, stock transactions, executive compensation, restricted stock units, stock appreciation rights, performance-based equity, insider trading, SEC Form 4